Literature DB >> 16100050

Crosstalk of beta-adrenergic receptor subtypes through Gi blunts beta-adrenergic stimulation of L-type Ca2+ channels in canine heart failure.

Jia-Qiang He1, Ravi C Balijepalli, Robert A Haworth, Timothy J Kamp.   

Abstract

The mechanisms underlying the blunted contractile response to beta-adrenergic receptor (beta-AR) stimulation in heart failure (HF) are incompletely understood, especially with regard to beta-AR subtype-specific regulation of L-type Ca2+ channels. We evaluated the impact of HF induced by pacing tachycardia on beta-AR regulation of L-type Ca2+ channels in a canine model. To evaluate changes in the relative subcellular distribution of beta-AR subtypes, left ventricular membranes enriched in surface sarcolemma and T-tubular sarcolemma were prepared. Radioligand binding using [(125)I]cyanopindolol revealed that HF resulted in a comparable decrease in the density of beta1-ARs in both surface and T-tubule sarcolemma (55+/-4%, n=7, P<0.001; and 45+/-10%, n=7, P<0.01, respectively), but no significant change in beta2-AR density was observed. Whole-cell patch clamp studies demonstrated a markedly blunted increase in I(Ca,L) in response to saturating concentrations of the nonselective beta-AR agonist isoproterenol (0.1 micromol/L) in failing myocytes compared with control (129+/-20%, n=11, versus 332+/-35%, n=7; P<0.001). Experiments testing beta1-AR- and beta2-AR-selective stimulation showed that the major component of the blunted response to nonselective beta-AR stimulation in HF was caused by beta2-AR activation, resulting in a pertussis toxin-sensitive, Gi-mediated inhibition of the beta1-AR-induced increase in I(Ca,L). In conclusion, canine HF results in the following: (1) a uniform reduction in beta1-AR density in surface and T-tubule membrane fractions without a change in beta2-AR density; and (2) the emergence of distinct Gi-coupling to beta2-ARs resulting in accentuated antagonism of beta1-AR-mediated stimulation of I(Ca,L). These results have implications for optimizing the use of beta-AR drugs in HF.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16100050     DOI: 10.1161/01.RES.0000181160.31851.05

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  22 in total

1.  The real estate of cardiac signaling: location, location, location.

Authors:  Meena S George; Geoffrey S Pitt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

Review 2.  Beta-blocker pharmacogenetics in heart failure.

Authors:  Jaekyu Shin; Julie A Johnson
Journal:  Heart Fail Rev       Date:  2008-04-24       Impact factor: 4.214

Review 3.  Different subcellular populations of L-type Ca2+ channels exhibit unique regulation and functional roles in cardiomyocytes.

Authors:  Jabe M Best; Timothy J Kamp
Journal:  J Mol Cell Cardiol       Date:  2011-08-23       Impact factor: 5.000

4.  Local control of β-adrenergic stimulation: Effects on ventricular myocyte electrophysiology and Ca(2+)-transient.

Authors:  Jordi Heijman; Paul G A Volders; Ronald L Westra; Yoram Rudy
Journal:  J Mol Cell Cardiol       Date:  2011-02-21       Impact factor: 5.000

5.  Phosphorylation of serine 1928 in the distal C-terminal domain of cardiac CaV1.2 channels during beta1-adrenergic regulation.

Authors:  Joanne T Hulme; Ruth E Westenbroek; Todd Scheuer; William A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-19       Impact factor: 11.205

6.  beta 2-Adrenergic stimulation is involved in the contractile dysfunction of the stunned heart.

Authors:  Leticia Vittone; Matilde Said; Alicia Mattiazzi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-03-31       Impact factor: 3.000

7.  RGS2 is a primary terminator of β₂-adrenergic receptor-mediated G(i) signaling.

Authors:  Khalid Chakir; Weizhong Zhu; Sharon Tsang; Anthony Yiu-Ho Woo; Dongmei Yang; Xianhua Wang; Xiaokun Zeng; Man-Hee Rhee; Ulrike Mende; Norimichi Koitabashi; Eiki Takimoto; Kendall J Blumer; Edward G Lakatta; David A Kass; Rui-Ping Xiao
Journal:  J Mol Cell Cardiol       Date:  2011-02-01       Impact factor: 5.000

8.  Mechanisms of enhanced beta-adrenergic reserve from cardiac resynchronization therapy.

Authors:  Khalid Chakir; Samantapudi K Daya; Takeshi Aiba; Richard S Tunin; Veronica L Dimaano; Theodore P Abraham; Kathryn M Jaques-Robinson; Kathryn Jacques; Edwin W Lai; Karel Pacak; Wei-Zhong Zhu; Rui-ping Xiao; Gordon F Tomaselli; David A Kass
Journal:  Circulation       Date:  2009-02-23       Impact factor: 29.690

9.  Beta-adrenergic adaptation in paediatric idiopathic dilated cardiomyopathy.

Authors:  Shelley D Miyamoto; Brian L Stauffer; Stephanie Nakano; Rebecca Sobus; Karin Nunley; Penny Nelson; Carmen C Sucharov
Journal:  Eur Heart J       Date:  2012-07-26       Impact factor: 29.983

10.  Opposing cardiac effects of autoantibody activation of β-adrenergic and M2 muscarinic receptors in cardiac-related diseases.

Authors:  Stavros Stavrakis; David C Kem; Eugene Patterson; Pedro Lozano; Shijun Huang; Bela Szabo; Madeleine W Cunningham; Ralph Lazzara; Xichun Yu
Journal:  Int J Cardiol       Date:  2010-01-06       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.